1
Cannabidiol reduces the brain activity linked to hallucinations, delusions and other forms of psychosis, research has found
Brain scans have revealed for the first time how a substance found in cannabis plants may help people with psychotic disorders by dampening down abnormal brain activity that arises in the patients.
A single dose of cannabidiol, an non-intoxicating extract of the plant, reduced unusual patterns of neural behaviour linked to hallucinations, delusions, and other symptoms of psychosis, researchers found.
The impact of the substance has raised hopes that medical preparations of pure cannabidiol, or new drugs based on the compound, may be turned into effective treatments for young people who develop psychosis but do not respond to existing therapies.
The most common treatments for psychosis today work on a brain chemical called dopamine, but no new drugs have been developed for the condition since they were discovered in the 1950s. “These results will clearly pave the way for developing a novel class of antipsychotic treatments,” said Sagnik Bhattacharyya, who led the research at King’s College London
Cannabis plants produce more than 100 active compounds known as cannabinoids. The most potent, and the substance responsible for the cannabis “high”, is THC or tetrahydrocannabinol. In the past two decades, cannabis with high levels of THC – about 15% – has come to dominate the market in the UK and elsewhere.
While high strength cannabis is suspected of raising the risk of mental health problems in some frequent cannabis users, cannabidiol or CBD appears to have opposite, antipsychotic properties. In illicit cannabis, there is too little CBD to have much beneficial effect, but researchers have long wondered whether doses of pure CBD may help to protect against psychosis.
“We knew from previous studies that CBD had antipsychotic effects, but we didn’t know how it worked,” said Bhattacharyya.
To find out, the researchers recruited 33 people who had all sought help for mild or occasional psychotic symptoms, such as hearing voices or having paranoid delusions. A single dose of cannabidiol was given to 16 of them, while the remaining 17 received an identical-looking placebo.
The scientists then watched how the volunteers’ brains behaved as they performed simple tasks in a magnetic resonance imaging machine. While in the brain scanner, the participants were asked to say whether pairs of words, such as ‘baby’ and ‘cries’ were related or not, and later, to recall the word that completed a pair when prompted by the scientists.
When the researchers compared scans from the different patient groups, and with scans from age and sex-matched healthy people, they found that the patients with psychotic symptoms had abnormal patterns of activity in three distinct brain regions, all of which are involved in psychosis. But in patients who had a single dose of CBD, the unusual brain activity appeared to be dampened down, making their scans more similar to those of health individuals. Details of the work are published in JAMA Psychiatry.
“This was just a single dose of CBD and that is not going to treat or cure psychosis,” said Bhattacharyya. “But this shows us that CBD at least has an effect on abnormal brain activity that is consistent with it being an antipsychotic.”
The King’s College researchers are now launching the first large scale trial to investigate whether pure, medical grade CBD is an effective treatment for young people who are at high risk of developing psychosis. The trial, which is expected to start recruiting early next year, is backed by the Medical Research Council and the National Institute for Health Research.
“If the trial shows it has efficacy, then the next step will be to get through the regulatory hurdles os using CBD in the clinic to treat patients,” said Bhattacharyya. “One shouldn’t get the impression that it’s OK to start prescribing CBD tomorrow.”
“We knew from previous studies that CBD had antipsychotic effects, but we didn’t know how it worked,” said Bhattacharyya.
Le CBD est un neurodysleptique qui agit mieux que le solian par exemple, car il a des effets secondaires nettement en sa faveur.
L'imagerie médicale montre les zones du cerveau qui retrouvent un "état normal" sous l'action du CBD.
Hors ligne
Hors ligne
Hors ligne
pierre a écrit
Merci pour l’etude ILE.
Quand tu mets une étude en anglais, Si tu pouvais traduire au moins les passages important que ça soit accessible au maximum de personnes ?
La traduction n'est pas mon fort, a fortiori dans le domaine médical.
Je vais essayer de faire un résumé.
Des chercheurs rapportent dans un article les résultats d'un essai clinique randomisé qui a examiné en imagerie fonctionnelle (IRM fonctionnelle) les effets du CBD sur des patients à haut risque clinique de psychose (mais non psychotiques), versus placebo et verso des contrôles témoins, pendant qu'ils exécutaient des tâches d'apprentissage verbal et restitution.
La dose orale de CBD donnée était de 600mg. Les résultats montrent que les patients qui ont pris le CBD ont des résultats intermédiaires entre ceux qui ont pris le placebo et les résultats des témoins.
Les chercheurs ont identifié en particulier 3 zones du cerveau dont le fonctionnement semblait normalisé / modulé par le cannabidiol : le striatum, le gyrus parahippocampique, et le mésencéphale. Ce sont des régions clés de la pathophysiologie de la psychose aussi l'effet thérapeutique du CBD sur les symptômes de la psychose s'expliquerait par son action sur ces 3 régions.
On connaissait déjà l'action antipsychotique du CBD mais sans en comprendre le fonctionnement. Suite à ces nouveaux résultats les chercheurs du King's College vont lancer un essai clinique de grande ampleur avec pour objectif à terme, si le CBD confirme son efficacité de franchir toutes les étapes réglementaires pour obtenir une autorisation de mise sur le marché.
1
[ Forum ] Actualité - Cannabis « médical » contre cannabis « récréatif » : une vision trop simpliste
|
2 | |
[ Forum ] Actualité - Un analogue du cannabis sans cannabis
|
3 | |
[ PsychoWIKI ] Les vaporisateurs de cannabis | ||
[ PsychoWIKI ] Comment réduire les problèmes respiratoires liés au cannabis | ||
[ QuizzZ ] Evaluer votre dépendance au cannabis
11707 personnes ont déja passé ce quizzz ! |